Probiotic Bacteria to Infants With Atopic Dermatitis

NCT01007331 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2010-02-17

No results posted yet for this study

Summary

The objective of the study is to examine whether 8 weeks intervention with probiotics influence the eczema in infants suffering from Atopic Dermatitis. Furthermore the influence of the immunologic status and the intestinal microflora, inflammation and permeability will be investigated.

Conditions

Interventions

BEHAVIORAL

Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07

10\^10 colony forming units pr day of probiotics

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Kim F Michaelsen, Professor · Department of Human Nutrition, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Denmark

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01007331 on ClinicalTrials.gov